#Japan #Tokyo #Animal Health #bitBiome #Kyoritsu Seiyaku

bitBiome and Kyoritsu Seiyaku: A Strategic Partnership in Animal Health

In a significant move within the biotechnology sector, bitBiome, Inc. has entered into a collaboration with Kyoritsu Seiyaku Corporation, a well-known leader in animal health based in Japan. This partnership aims to leverage advanced biotechnological innovations to improve health and nutrition solutions for animals worldwide.

Advancing Animal Healthcare

The joint initiative, as announced on March 9, 2026, will focus on the co-development of innovative products using cutting-edge biotechnology. bitBiome, recognized for its groundbreaking research in bio-manufactured products, will spearhead the development of these new solutions. With plans to commercialize and promote the resulting technologies globally, this collaboration promises to foster an enhanced approach to animal healthcare.

bitBiome's capabilities stem from its sophisticated technology platform, which integrates an extensive microbial sequence database with advanced enzyme technology. This unique combination allows the company to create effective, affordable biological solutions efficiently.

Kyoritsu Seiyaku, with decades of experience in veterinary medicine, brings its historical knowledge and commitment to animal welfare into this partnership. The alliance is expected to result in market-ready products that effectively address the needs of livestock and pets while promoting sustainable veterinary practices.

A Commitment to Sustainability

Yuji Suzuki, CEO of bitBiome, expressed his enthusiasm for the partnership, emphasizing that the focus on bio-based products is crucial for building a more sustainable global economy. According to Suzuki, the partnership will play a vital role in enhancing the quality of health management for animals worldwide using innovative technologies.

This focus aligns with Kyoritsu Seiyaku’s mission, reinforcing their longstanding tradition of enhancing animal health through effective pharmaceutical solutions designed for both pets and livestock. The collaboration's aim is not only to create effective products but also to tackle broader societal challenges, including the push for a more sustainable society through advanced biotechnological applications.

About Kyoritsu Seiyaku Corporation

Founded in 1955, Kyoritsu Seiyaku Corporation has been at the forefront of animal health for over six decades. The company is dedicated to developing, manufacturing, selling, importing, and exporting pharmaceuticals designed for dogs, cats, and livestock. Its President and CEO, Takaaki Takai, leads a team of 728 employees (as of May 2025). With a steadfast commitment to ensuring the wellbeing of animals, Kyoritsu seeks to integrate advanced biotechnology solutions into practical applications that benefit both animals and their owners.

About bitBiome

bitBiome's mission revolves around unlocking the planet's microbiotal potential to support the bioeconomy. Utilizing their proprietary technologies, such as the bit-MAP® single-cell microbial genome analysis, they curate a vast microbial database that comprises over 2.5 billion sequences, many of which are not found in public databases. The company is also devoted to improving biomanufacturing methods, aiming to introduce innovative nature-inspired products into the market. Their bit-QED platform streamlines the process of enzyme discovery and proprietary strain engineering, enabling rapid and affordable bio-based product development.

This collaboration between bitBiome and Kyoritsu Seiyaku signifies a promising future for advancements in animal health and nutrition, ensuring that both livestock and pets benefit from cutting-edge biotechnological solutions. As these two companies combine their expertise, the focus remains on improving animal wellbeing while also promoting sustainability in a rapidly evolving global market.

For further updates on this collaboration and more about both companies’ offerings, visit their respective official websites.